October 6, 2020
“ConocoPhillips (COP)… Overall, the Strong Buy consensus rating on COP shares is based on 13 reviews, including 11 Buys and 2 Holds. The stock sells for $33.90 and has an average price target of $48.08, in line with Gresh’s… Baker… Continue Reading…
October 5, 2020
“Kala Pharmaceuticals (KALA)… In general, other analysts echo Moussatos’ sentiment. 4 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $20.80, the upside potential comes in at 173%… Revance Therapeutics (RVNC)…… Continue Reading…
October 5, 2020
“SLM Corporation (SLM)… Overall, SLM has a Strong Buy rating from the analyst consensus, based on 4 reviews breaking down to 3 Buys and 1 Hold. The shares are selling for $7.97, and their average price target of $9.33 indicates room… Continue Reading…
October 4, 2020
“Just because a stock is trading near all-time highs doesn’t mean it’s overvalued. With that being said, it’s hard to imagine how these equities could be perfectly priced when you consider all they stand to lose… Tesla (NASDAQ:TSLA) Workhorse (NASDAQ:WKHS) Apple (NASDAQ: AAPL) Zoom (NASDAQ:ZM)… Continue Reading…
October 4, 2020
“Wix.com Ltd (WIX)… Where do other analysts stand on Wix? 14 Buys and 1 Hold have been issued in the last three months. Therefore, WIX gets a Strong Buy consensus rating. Given the $333.93 average price target, shares could surge… Continue Reading…
October 3, 2020
“Kraft Heinz Co. (KHC)… Kraft Heinz is not only one of Buffett’s largest holdings but also one of the highest-yielding stocks in Berkshire’s portfolio. Kraft Heinz shares have a 5.3% dividend… Store Capital Corp. (STOR)… Store Capital is a net-lease real estate investment… Continue Reading…
October 3, 2020
“Saratoga Investment Corporation (SAR)… Overall, Saratoga gets a unanimous Strong Buy rating from the analyst consensus, based on 3 recent positive reviews. The shares are selling for $17.02 and have an average price target of $22.58, slightly more bullish than Alexander’s… Continue Reading…
October 2, 2020
“Kintara Therapeutics (KTRA)… Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the word on the Street is that KTRA is a Strong Buy. Given the… Continue Reading…
October 1, 2020
“When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he’s reaping the rewards. It was the gamble of… Continue Reading…
October 1, 2020
“PDC Energy (PDCE)… Are other analysts in agreement? They are. Only Buy ratings, 11, in fact, have been issued in the last three months. Therefore, the verdict is unanimous: PDCE is a Strong Buy. Given the $21.50 average price target,… Continue Reading…
Recent Comments